Scarica l'app Stockscreener
24.46
0.82%
0.20
Dopo l'orario di chiusura:
24.34
-0.12
-0.49%
Precedente Chiudi:
$24.26
Aprire:
$24.1
Volume 24 ore:
683.32K
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.48B
Reddito:
$688.00K
Utile/perdita netta:
$-170.19M
Rapporto P/E:
-8.021
EPS:
-3.0495
Flusso di cassa netto:
$-154.68M
1 W Prestazione:
+4.66%
1M Prestazione:
+45.94%
6M Prestazione:
+60.60%
1 anno Prestazione:
-24.81%
Intervallo 1D:
$23.65
$24.59
Intervallo di 1 settimana:
$23.52
$25.05
Portata 52W:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
Nome
Spyre Therapeutics Inc
Settore
Industria
Telefono
(617) 651-5940
Indirizzo
221 CRESCENT STREET, WALTHAM
Confronta SYRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
24.46 | 1.88B | 688.00K | -170.19M | -154.68M | -3.0495 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-26 | Iniziato | Deutsche Bank | Buy |
| 2025-04-08 | Iniziato | Leerink Partners | Outperform |
| 2025-03-18 | Iniziato | Wolfe Research | Outperform |
| 2024-09-04 | Iniziato | Wedbush | Outperform |
| 2024-07-16 | Iniziato | Evercore ISI | Outperform |
| 2024-05-02 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | Iniziato | BTIG Research | Buy |
| 2023-12-11 | Iniziato | Guggenheim | Buy |
| 2023-12-11 | Iniziato | Jefferies | Buy |
| 2020-05-04 | Iniziato | Piper Sandler | Overweight |
| 2019-03-21 | Iniziato | JP Morgan | Overweight |
| 2018-09-04 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | Iniziato | Evercore ISI | Outperform |
| 2018-03-14 | Reiterato | Needham | Buy |
Mostra tutto
Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie
Why Spyre Therapeutics Inc. stock remains on watchlistsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Why retail investors favor Spyre Therapeutics Inc. stockJuly 2025 Short Interest & AI Optimized Trade Strategies - newser.com
Using Ichimoku Cloud for Spyre Therapeutics Inc. technicalsMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
Is a relief rally coming for Spyre Therapeutics Inc. holdersWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Can Spyre Therapeutics Inc. stock sustain free cash flow growth2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Will Spyre Therapeutics Inc. stock recover faster than peers2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Will Spyre Therapeutics Inc. (3920) stock sustain uptrend momentumBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com
What insider purchases suggest about Spyre Therapeutics Inc. (3920) stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-02 03:35:20 - newser.com
What dividend safety score for Spyre Therapeutics Inc. stock2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
Is Spyre Therapeutics Inc. (3920) stock inflation resilient2025 Analyst Calls & Risk Managed Investment Signals - newser.com
Why Spyre Therapeutics Inc. stock remains undervalued2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Will Spyre Therapeutics Inc. stock deliver strong dividend growth2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Earnings visualization tools for Spyre Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
What sentiment indicators say about Spyre Therapeutics Inc. stock2025 Price Momentum & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-01 04:11:34 - newser.com
Spyre Therapeutics (SYRE) to Release Quarterly Earnings on Thursday - MarketBeat
Will Spyre Therapeutics Inc. stock maintain dividend yieldWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Is Spyre Therapeutics Inc. stock a buy for dividend growthJuly 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
What drives Spyre Therapeutics Inc 3920 stock priceInsider Buying Signals & Free Professional Investment Consultations - earlytimes.in
Will Spyre Therapeutics Inc. stock sustain high P E ratiosJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Spyre Therapeutics, Inc. $SYRE Shares Sold by Emerald Mutual Fund Advisers Trust - MarketBeat
Best data tools to analyze Spyre Therapeutics Inc. stockJuly 2025 Action & Weekly Breakout Watchlists - newser.com
Is Spyre Therapeutics Inc. (3920) stock at risk of policy regulationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Is Spyre Therapeutics Inc. (3920) stock undervalued after correctionMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Will Spyre Therapeutics Inc. (3920) stock beat international competitionJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
How to escape a deep drawdown in Spyre Therapeutics Inc.Gap Down & Weekly Return Optimization Plans - newser.com
Backtesting results for Spyre Therapeutics Inc. trading strategiesQuarterly Investment Review & Community Trade Idea Sharing - newser.com
Emerald Advisers LLC Boosts Stake in Spyre Therapeutics, Inc. $SYRE - MarketBeat
Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):